Altre lingue FibroGen, Inc.

Azioni

FGEN

US31572Q8087

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 19/04/2024			Variaz. 5gg	Var. 1 gen.
1,15 ^USD	-1,71%		-11,54%	+29,75%

15/04	Faron Pharmaceuticals nomina nuovamente l'ex responsabile finanziario ad interim	AN
03/04	I principali ribassisti di mezzogiorno	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Faron Pharmaceuticals reappoints former finance chief on interim basis	15/04
Top Midday Decliners	03/04
FibroGen Says Phase 1 Study of Potential Prostate Cancer Treatment Shows Promise	03/04
FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer	02/04
Fibrogen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer	02/04
FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference	26/03
FibroGen : Corporate Presentation – March 2024	19/03
Sector Update: Health Care Stocks Rise Late Afternoon	12/03
Sector Update: Health Care Stocks Higher in Afternoon Trading	12/03
FibroGen Shares Jump After CEO Stock Purchase	12/03
FibroGen Names Deyaa Adib Chief Medical Officer	11/03
FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer	11/03
FibroGen Appoints Deyaa Adib as Senior Vice President and Chief Medical Officer	11/03
FibroGen : Corporate Presentation – March 2024	06/03
FibroGen: Q4 Earnings Snapshot	26/02
FibroGen regains rights to anemia drug from AstraZeneca	26/02
FibroGen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Earnings Flash (FGEN) FIBROGEN Reports Q4 Revenue $27.1M, vs. Street Est of $38.8M	26/02
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results	26/02
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZeneca Territories, Except China and South Korea	26/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue FibroGen, Inc.

Azioni

FGEN

US31572Q8087

Altre lingue

Filtri